Global Assisted Reproductive Technology Market Size and Forecast 2023-2032|Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited,

Assisted reproductive technology in fertility treatment concept

The Assisted Reproductive Technology Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Assisted Reproductive Technology Market:

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

According to The Business Research Company’s Assisted Reproductive Technology Global Market Report 2024, The assisted reproductive technology market size has grown rapidly in recent years. It will grow from $38.04 billion in 2023 to $45.42 billion in 2024 at a compound annual growth rate (CAGR) of 19.4%. The growth in the historic period can be attributed to increase in infertility rates, changing societal norms, growing awareness, legislative support, aging population.

The assisted reproductive technology market size is expected to see rapid growth in the next few years. It will grow to $91.8 billion in 2028 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to increasing maternal age, rising demand for same-sex parenting, medical tourism, expanding healthcare infrastructure, research and development. Major trends in the forecast period include use of artificial intelligence (ai), egg freezing, single-embryo transfer (set), pgt-a and genetic screening, innovative fertility preservation techniques.

The rising number of infertility cases is expected to foster the assisted reproductive technology market in the coming years. Infertility is defined as the failure to become pregnant after a year of frequent and unprotected intercourse. Infertility affects both men and women, and is typically diagnosed by the inability to conceive. Infertility is treated using assisted reproductive technology (ART). Fertility therapies that work with both a woman’s egg and a man’s sperm are included in this. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based international public health organization, millions of people in the world who are of reproductive age will struggle with infertility, which will also influence their families and communities. Worldwide, it is estimated that 1 in 6 adults or around 17.5% of the global adult population struggle with infertility. Therefore, the rising number of infertility cases drives the growth of the assisted reproductive technology market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

The assisted reproductive technology market covered in this report is segmented –

1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing

2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking

3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Technological advancements is a key trend gaining the popularity in the assisted reproductive technology market. Major companies operating in the assisted reproductive technology are focused on developing technological solutions to strengthen their position. For instance, in October 2022, Alife Health, a US-based medical equipment manufacturing company launched Alife Assist platform, a suite of products designed to revolutionize the in-vitro fertilization (IVF) process by harnessing data-driven insights and artificial intelligence (AI) to aid clinical decision-making during key IVF stages and streamline the operations of fertility clinics. This innovative platform, comprised of Stim Assist, Embryo Assist, and Insights, offers comprehensive support to reproductive endocrinologists, embryologists, and clinic administrators, improving medication dosing, embryo grading, and real-time performance monitoring, ultimately enhancing the patient experience and success rates in IVF procedures.

The assisted reproductive technology market report table of contents includes:

1. Executive Summary

2. Assisted Reproductive Technology Market Characteristics

3. Assisted Reproductive Technology Market Trends And Strategies

4. Assisted Reproductive Technology Market – Macro Economic Scenario

5. Global Assisted Reproductive Technology Market Size and Growth

26. South America Assisted Reproductive Technology Market

27. Brazil Assisted Reproductive Technology Market

28. Middle East Assisted Reproductive Technology Market

29. Africa Assisted Reproductive Technology Market

30. Assisted Reproductive Technology Market Competitive Landscape And Company Profiles

Top Major Players: